Conversation Starters
INDICATION

DESCOVY® for HIV-1 pre-exposure prophylaxis (PrEP) is indicated in at-risk adults and adolescents (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection, excluding individuals at risk from receptive vaginal sex. HIV-1–negative status must be confirmed immediately prior to initiation.

Limitation of Use: DESCOVY FOR PrEP® is not indicated in individuals at risk of HIV-1 from receptive vaginal sex because effectiveness in this population has not been evaluated.

Be the catalyst to spark a conversation about HIV risk and prevention

Only 23% and 47% of sexually active men and women, respectively, report receiving a sexual risk assessment, despite visiting a healthcare provider in the past year1

Uncover HIV risk by starting a dialogue with patients about:

STI History

"Have you or your partner(s) ever had an STI?"2

HIV testing habits

"Do you tend to get tested for HIV regularly or just when you think you may have been exposed?"3

Sexual relationships

"Is your sexual partner(s) new or long-term? Are you and your partner(s) in an open relationship?"2

STI=sexually transmitted infection.